Navigation Links
Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
Date:3/25/2008

on drug efficacy. These earlier trials demonstrated significant activity even at a 0.5% concentration of AN2728, the lowest concentration tested.

About Psoriasis

Affecting approximately 10 million people worldwide, psoriasis is an inflammation of the skin caused by a reaction of the immune system. It is characterized by thickened patches of inflamed, red skin covered with thick, silvery scales typically found at the elbows, knees, scalp and genital areas.

About Anacor Pharmaceuticals

Anacor is a biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform. Anacor has focused initially on developing topical applications of its compounds to treat fungal, bacterial and inflammatory diseases. Anacor's most advanced product candidate is AN2690, a novel topical antifungal in development for the treatment of toenail onychomycosis, which is a fungal infection of the nail and nail bed. Anacor entered into a worldwide license, development and commercialization agreement for AN2690 with Schering-Plough for all indications including the treatment of onychomycosis. Anacor also has a research and development collaboration with GlaxoSmithKline for the discovery, development, manufacture and worldwide commercialization of novel systemic therapeutics for viral and bacterial diseases utilizing Anacor's boron-based chemistry. For more information visit http://www.anacor.com.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding the progress and timing of our clinical trials and the safety and efficacy of our product candidates. These statements relate to future events and involve known and unknown risks, uncertainties and other factors that could cause actual levels of activity, performance or achievement to differ materially from those expressed or implied by these forward-looking st
'/>"/>

SOURCE Anacor Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
2. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
3. VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial
4. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
5. BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
6. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
7. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
8. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
9. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
10. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
11. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 , ... Microplasmin Recruits a Total of Over,640 patients ... ThromboGenics NV (Euronext Brussels: THR), a ... of innovative treatments for eye,disease, vascular disease ... completed,the enrolment of the second Phase III ...
(Date:12/15/2009)... Corporation (Nasdaq: VOLC ), a leading developer ... Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Forward ... designed to enhance the diagnosis and treatment of ... placement of over 2,500 s5 family consoles worldwide. ... launched in April 2006, with more than 1,000 ...
(Date:12/15/2009)... CITY, Dec. 15 Sonic Innovations, Inc. ... services and solutions, donated $10,000 to its local ... Dec. 14, 2009. ,, Sonic Innovations President Paul ... Feeding America member, the Utah Food Bank, at ... employees also participated in an office food drive ...
Breaking Medicine Technology:ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Volcano Announces Installed Base Growth Milestone 2Volcano Announces Installed Base Growth Milestone 3Volcano Announces Installed Base Growth Milestone 4Volcano Announces Installed Base Growth Milestone 5Sonic Innovations, Inc. Donates $10,000 to Feeding America 2Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 50195 1Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 50195 2Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 50195 3Photos 3A Selecciones Readers Digest The American Heart Associations Go Red For Women and Macys Reach Hispanic Women With Message of Heart Health 50191 1Photos 3A Selecciones Readers Digest The American Heart Associations Go Red For Women and Macys Reach Hispanic Women With Message of Heart Health 50191 2Researchers see evidence of memory in the songbird brain 9024 1Researchers see evidence of memory in the songbird brain 9024 2
... July 10, 2007 /CNW/ - Protox,Therapeutics Inc. (TSX-V:PRX) today ... trial evaluating ,PRX302 in patients with localized, recurrent prostate ... is safe and well tolerated and shows promising ... , ,"The completion of ...
... PORTLAND, Ore.--(BUSINESS WIRE)--Jul 10, 2007 - AVI BioPharma, ... has,completed target patient enrollment and released six-month,follow-up data ... Appraisal.,The trial, currently being held in Germany, was ... drug Resten-MP(TM), when,used in conjunction with the placement ...
Other Medicine Technology:Protox Announces Positive Clinical Data from Prostate Cancer Study 2Protox Announces Positive Clinical Data from Prostate Cancer Study 3Protox Announces Positive Clinical Data from Prostate Cancer Study 4Protox Announces Positive Clinical Data from Prostate Cancer Study 5AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2
(Date:12/16/2009)... Podiatric Medical Association’s Seal of Acceptance , ... ... shoppers continue their search for the perfect gift this season, ... that are considered healthy for the environment. When it comes ... today’s most stylish items are also healthy for feet—making a ...
(Date:12/16/2009)... of products that help survivors of stroke and other forms ... of an interview with the inventors of their brand new ... and Rehab Medicine, vol. 20, issue 20, page 26, 2009; ... ... (PRWEB) December 16, 2009 -- In the publication, entitled ...
(Date:12/16/2009)... are rapidly approaching and what would be the perfect gift to ... of course! Celebrity Beauty Engineer® and Licensed Esthetician Mary Schook introduces ... look and feel their best! , ... (PRWEB) December ... of gift does a person get that special woman who has ...
(Date:12/15/2009)... successfully developed a new electrophoretic method for detecting ... The technique, using SARCOSYL-PAGE, has specifically enhanced ... performance characteristics of SDS-PAGE for detecting other EPOs. ... grant from the World Anti-Doping Agency (WADA), appear ... and Analysis published by Wiley-Blackwell. , MIRCERA ...
(Date:12/15/2009)... Watchdog Calls For Preserving State Authority, Ban on ... ,, WASHINGTON, Dec. 15 Consumer Watchdog ... for those over 55 and the public option ... the group said that the Senate must still ... bill to prevent ceding the entire health care ...
Breaking Medicine News(10 mins):Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 2Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 3Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 4Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:Researchers discover novel method for detecting MIRCERA 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5
... Sept. 4 BlueCross BlueShield of South,Carolina plans ... plans and make these available in real time ... Together with ParadigmHealth, a provider and integrator of ... make the new Integrated,Care Management platform available to ...
... Should doctors be,involved in the state-ordered administration of ... Proceedings, three anesthesiologists and a,medical ethicist take an ... and,two editorials., None of these articles debate ... the current position of the,American Medical Association (AMA), ...
... rate when parents took part in therapy , , TUESDAY, Sept. ... in the treatment of teens with bulimia, a new study ... program, the percentage of teens able to abstain from the ... have often been seen as part of the problem, rather ...
... of common allergens, OMAHA, Neb., Sept. 4 Everyday ... bombarded by contaminants and,allergens, such as dust mites, animal dander, ... that any air that gets in --,good or bad -- ... the more important. Try to prevent as many allergens ...
... Endocrinologists (AACE) and Lilly join to, provide patients and physicians with ... ... season arrives, INDIANAPOLIS and JACKSONVILLE, Fla., Sept. 4 With,hurricane ... disasters hitting communities across the United States, the,American Association of Clinical ...
... Services (TCS),(BSE: TCS.BO, NSE: TCS.NS), a leading IT ... of the world,s leading research-focused,healthcare groups in the ... have announced a partnership to,advance Roche,s Global Capacity ... provide services to a number of areas in,Roche,s ...
Other Medicine News:Health News:S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time 2Health News:S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time 3Health News:Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment 2Health News:Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment 3Health News:Parental Involvement Key to Battling Bulimia 2Health News:Parental Involvement Key to Battling Bulimia 3Health News:Clean to Ease Allergy and Asthma Symptoms 2Health News:Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions 2Health News:Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions 3Health News:Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions 4Health News:Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions 5Health News:Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions 6Health News:Tata Consultancy Services to Support Roche's Global Capacity Building Initiative 2Health News:Tata Consultancy Services to Support Roche's Global Capacity Building Initiative 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: